Glafenine
Glafenine
![](../I/m/Glafenine.svg.png) |
Systematic (IUPAC) name |
---|
2,3-Dihydroxypropyl 2-[(7-chloro-4-quinolinyl)amino]benzoate |
Clinical data |
---|
Identifiers |
---|
|
3820-67-5 |
---|
|
N02BG03 |
---|
PubChem |
CID 3474 |
---|
ChemSpider |
3355 |
---|
ChEBI |
CHEBI:31653 Y |
---|
Chemical data |
---|
Formula |
C19H17ClN2O4 |
---|
|
372.802 g/mol |
---|
SMILES
- O=C(OCC(O)CO)c1ccccc1Nc2c3ccc(Cl)cc3ncc2
|
InChI=1S/C19H17ClN2O4/c20-12-5-6-14-17(7-8-21-18(14)9-12)22-16-4-2-1-3-15(16)19(25)26-11-13(24)10-23/h1-9,13,23-24H,10-11H2,(H,21,22)
Key:GWOFUCIGLDBNKM-UHFFFAOYSA-N
|
Glafenine is a non-steroidal anti-inflammatory drug (NSAID). Use of glafenine is limited due to the risk of anaphylaxis and acute kidney failure.[1][2]
See also
References
- ↑ "Withdrawal of glafenine". The Lancet 339 (8789): 357. 1992. doi:10.1016/0140-6736(92)91670-4.
- ↑ Kleinknecht, D; Landais, P; Goldfarb, B (1986). "Analgesic and non-steroidal anti-inflammatory drug-associated acute renal failure: A prospective collaborative study". Clinical nephrology 25 (6): 275–81. PMID 2873910.
|
---|
| Opioids | |
---|
| Anilines | |
---|
| NSAIDs | |
---|
| Cannabinoids | |
---|
| Channelergics | |
---|
| Myorelaxants | |
---|
| Others | |
---|
|
| | |
---|
| Description |
- Anatomy
- meninges
- cortex
- association fibers
- commissural fibers
- lateral ventricles
- basal ganglia
- diencephalon
- mesencephalon
- pons
- cerebellum
- medulla
- spinal cord
- Physiology
- Development
|
---|
| Disease |
- Cerebral palsy
- Meningitis
- Demyelinating diseases
- Seizures and epilepsy
- Headache
- Stroke
- Sleep
- Congenital
- Injury
- Neoplasms and cancer
- Other
- Symptoms and signs
- head and neck
- eponymous
- lesions
- Tests
|
---|
| Treatment |
- Procedures
- Drugs
- general anesthetics
- analgesics
- addiction
- epilepsy
- cholinergics
- migraine
- Parkinson's
- vertigo
- other
|
---|
|
|